BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kuei A, Saab S, Cho SK, Kee ST, Lee EW. Effects of Yttrium-90 selective internal radiation therapy on non-conventional liver tumors. World J Gastroenterol 2015; 21(27): 8271-8283 [PMID: 26217079 DOI: 10.3748/wjg.v21.i27.8271] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Golse N, Adam R. Liver Metastases From Breast Cancer: What Role for Surgery? Indications and Results. Clinical Breast Cancer 2017;17:256-65. [DOI: 10.1016/j.clbc.2016.12.012] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
2 Frilling A, Ebert M. Treatment of Non-Colorectal Liver Metastases. Viszeralmedizin 2015;31:386. [PMID: 26889140 DOI: 10.1159/000442900] [Reference Citation Analysis]
3 Young S, Taylor A, Golzarian J, Flanagan S, D'souza D, Sanghvi T. Clinical utility of one month imaging following selective internal radiation therapy. Diagnostic and Interventional Imaging 2019;100:39-46. [DOI: 10.1016/j.diii.2018.07.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
4 Courtney D, Davey MG, Moloney BM, Barry MK, Sweeney K, McLaughlin RP, Malone CM, Lowery AJ, Kerin MJ. Breast cancer recurrence: factors impacting occurrence and survival. Ir J Med Sci 2022. [PMID: 35076871 DOI: 10.1007/s11845-022-02926-x] [Reference Citation Analysis]
5 Najran P, Lamarca A, Mullan D, McNamara MG, Westwood T, Hubner RA, Lawrence J, Manoharan P, Bell J, Valle JW. Update on Treatment Options for Advanced Bile Duct Tumours: Radioembolisation for Advanced Cholangiocarcinoma. Curr Oncol Rep 2017;19:50. [PMID: 28656502 DOI: 10.1007/s11912-017-0603-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
6 Kis B, Shah J, Choi J, El-Haddad G, Sweeney J, Biebel B, Mellon E, Frakes JM, Hoffe SE, Fishman MN, Shridhar R. Transarterial Yttrium-90 Radioembolization Treatment of Patients with Liver-Dominant Metastatic Renal Cell Carcinoma. J Vasc Interv Radiol 2017;28:254-9. [PMID: 27955832 DOI: 10.1016/j.jvir.2016.09.025] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
7 Kayaleh R, Krzyston H, Rishi A, Naziri J, Frakes J, Choi J, El-Haddad G, Parikh N, Sweeney J, Kis B. Transarterial Radioembolization Treatment of Pancreatic Cancer Patients with Liver-Dominant Metastatic Disease Using Yttrium-90 Glass Microspheres: A Single-Institution Retrospective Study. J Vasc Interv Radiol. 2020;31:1060-1068. [PMID: 32534978 DOI: 10.1016/j.jvir.2019.11.037] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
8 Ghodadra A, Xing M, Zhang D, Kim HS. Yttrium-90 Radioembolization Is Cost Effective in Intrahepatic Cholangiocarcinoma: A SEER Medicare Population Study. J Vasc Interv Radiol 2019;30:293-7. [PMID: 30819468 DOI: 10.1016/j.jvir.2018.07.033] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Young S, Chen T, Flanagan S, Golzarian J, Sanghvi T. Realized tumor to normal ratios in hepatocellular carcinoma patients undergoing transarterial radioembolization: a retrospective evaluation. Eur Radiol 2022. [PMID: 35032212 DOI: 10.1007/s00330-021-08501-9] [Reference Citation Analysis]
10 Zane KE, Cloyd JM, Mumtaz KS, Wadhwa V, Makary MS. Metastatic disease to the liver: Locoregional therapy strategies and outcomes. World J Clin Oncol 2021; 12(9): 725-745 [PMID: 34631439 DOI: 10.5306/wjco.v12.i9.725] [Reference Citation Analysis]
11 Boone BA, Perkins S, Bandi R, Santos E, McCluskey K, Bartlett DL, Pingpank JF. Hepatic artery infusion of melphalan in patients with liver metastases from ocular melanoma. J Surg Oncol 2018;117:940-6. [PMID: 29878390 DOI: 10.1002/jso.24984] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
12 Helmberger T, Golfieri R, Pech M, Pfammatter T, Arnold D, Cianni R, Maleux G, Munneke G, Pellerin O, Peynircioglu B, Sangro B, Schaefer N, de Jong N, Bilbao JI; On behalf of the CIRT Steering Committee., On behalf of the CIRT Principal Investigators. Clinical Application of Trans-Arterial Radioembolization in Hepatic Malignancies in Europe: First Results from the Prospective Multicentre Observational Study CIRSE Registry for SIR-Spheres Therapy (CIRT). Cardiovasc Intervent Radiol 2021;44:21-35. [PMID: 32959085 DOI: 10.1007/s00270-020-02642-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
13 Tafti BA, Padia SA. Dosimetry of Y-90 Microspheres Utilizing Tc-99m SPECT and Y-90 PET. Semin Nucl Med 2019;49:211-7. [PMID: 30954187 DOI: 10.1053/j.semnuclmed.2019.01.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
14 Abbott AM, Doepker MP, Kim Y, Perez MC, Gandle C, Thomas KL, Choi J, Shridhar R, Zager JS. Hepatic Progression-free and Overall Survival After Regional Therapy to the Liver for Metastatic Melanoma. Am J Clin Oncol 2018;41:747-53. [PMID: 28059929 DOI: 10.1097/COC.0000000000000356] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 6.7] [Reference Citation Analysis]
15 Willems E, Smet B, Dedeurwaerdere F, D'Hondt M. Foreign body granuloma reaction following SIRT mimicking peritoneal metastases: a word of caution. Acta Chir Belg 2020;120:47-9. [PMID: 30092710 DOI: 10.1080/00015458.2018.1494969] [Reference Citation Analysis]
16 Rostas J, Tam A, Sato T, Kelly L, Tatum C, Scoggins C, McMasters K, Martin RCG 2nd. Image-Guided Transarterial Chemoembolization With Drug-Eluting Beads Loaded with Doxorubicin (DEBDOX) for Unresectable Hepatic Metastases from Melanoma: Technique and Outcomes. Cardiovasc Intervent Radiol 2017;40:1392-400. [PMID: 28508253 DOI: 10.1007/s00270-017-1651-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
17 Zubiri L, Bilbao JI, Rodríguez J, Sangro B. Selective internal radiation therapy: an effective treatment for hormonal syndromes in pancreatic neuroendocrine tumors. Hepat Oncol 2018;5:HEP09. [PMID: 31293777 DOI: 10.2217/hep-2017-0025] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Whooley PD, Flores JP, Fotoohi M, Lin BS. Palliative TACE for hepatic metastases of chromophobe renal cell carcinoma. BMJ Case Rep 2019;12:e229207. [PMID: 31308185 DOI: 10.1136/bcr-2019-229207] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Chan KT, Alessio AM, Johnson GE, Vaidya S, Kwan SW, Monsky W, Wilson AE, Lewis DH, Padia SA. Prospective Trial Using Internal Pair-Production Positron Emission Tomography to Establish the Yttrium-90 Radioembolization Dose Required for Response of Hepatocellular Carcinoma. International Journal of Radiation Oncology*Biology*Physics 2018;101:358-65. [DOI: 10.1016/j.ijrobp.2018.01.116] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 7.8] [Reference Citation Analysis]
20 Helmberger T, Arnold D, Bilbao JI, de Jong N, Maleux G, Nordlund A, Peynircioglu B, Sangro B, Sharma RA, Walk A. Clinical Application of Radioembolization in Hepatic Malignancies: Protocol for a Prospective Multicenter Observational Study. JMIR Res Protoc 2020;9:e16296. [PMID: 32319960 DOI: 10.2196/16296] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Rostas JW, Tam AL, Sato T, Scoggins CR, McMasters KM, Martin RCG 2nd. Health-related quality of life during trans-arterial chemoembolization with drug-eluting beads loaded with doxorubicin (DEBDOX) for unresectable hepatic metastases from ocular melanoma. Am J Surg 2017;214:884-90. [PMID: 28754534 DOI: 10.1016/j.amjsurg.2017.07.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
22 Dimitroulis D, Damaskos C, Valsami S, Davakis S, Garmpis N, Spartalis E, Athanasiou A, Moris D, Sakellariou S, Kykalos S, Tsourouflis G, Garmpi A, Delladetsima I, Kontzoglou K, Kouraklis G. From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world. World J Gastroenterol 2017; 23(29): 5282-5294 [PMID: 28839428 DOI: 10.3748/wjg.v23.i29.5282] [Cited by in CrossRef: 118] [Cited by in F6Publishing: 113] [Article Influence: 23.6] [Reference Citation Analysis]
23 Bergamini C, Cavalieri S, Cascella T, Lanocita R, Alfieri S, Resteghini C, Platini F, Orlandi E, Locati LD, Marchianò A, Licitra L. Local therapies for liver metastases of rare head and neck cancers: a monoinstitutional case series. Tumori 2021;107:188-95. [PMID: 32924878 DOI: 10.1177/0300891620952844] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Yuan WH, Li AF, Hsu HC, Hu YS, Lee RC. Initial clinical radiological findings and staging to predict prognosis of primary hepatic angiosarcoma: A retrospective analysis. PLoS One 2019;14:e0225043. [PMID: 31710641 DOI: 10.1371/journal.pone.0225043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]